Skip to content

Clinical trials

Pancreatic Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Country / region: Netherlands Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20051
20064
20071
20092
20102
20114
20122
20135
20146
20158
20167
20177
20183
20193
20204
20217
20226
202310
20247
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Unknown status18
Recruiting14
Terminated12
Active, not recruiting10
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)17
Radboud University Medical Center9
Amsterdam UMC, location VUmc5
Novartis Pharmaceuticals5
UMC Utrecht5
Amgen4
European Organisation for Research and Treatment of Cancer - EORTC4
Maastricht University Medical Center4
Hoffmann-La Roche3
AstraZeneca2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms101
Neoplasms16
Carcinoma, Non-Small-Cell Lung12
Colorectal Neoplasms11
Ovarian Neoplasms8
Breast Neoplasms7
Esophageal Neoplasms7
Lung Neoplasms7
Rectal Neoplasms7
Stomach Neoplasms7

Trials

Showing 51 to 75 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.